2[2]Report of Expert Committee onthe diagnosis and classification of diabetes mellitus.Diabetes Care 2001;24(Suppl 1):S5-S20.
3[4]Ceriello A. The postprandial state and the risk of atherosclerosis. Diabetes Care 1997; 23: S6 - 11.
4[5]Coutinho M, et al. The relationship between glucose and incident cardiovascular events. Diabetes Care 1999; 22 (2): 223- 240.
5[6]Lefebrre PJ, Scheen AJ. The postprandial State risk of Cardio Vascular disease. Diabet Med 1988; 15 (Suppl 4) : 363 -368.
6[7]Chiasson JL, Josse RG, Hunt JA, et al. The efficacy of acarbose in the treatment of patients with non - insulin - dependent diabetes mellitus: a multicenter, controlled clinical trial [J].Ann Intern Med 1994;121:928.
7[8]Lkenoue T, Okazaki K, Fujitani S, et al. Effect of a new hypoglycemic agent, A - 4166 [ ( - ) - N - ( trans - 4 - isopropylcyclhexanecarbonyl) - D - phenylalanine], on postprandial blood glucose excursion: comparison with voglibose and glibenclamide [J]. Biol Pharm Bull 1997;20(4) :354.
8Hanefeld M. Fischer S. Julius U. et al and Dis Group Risk factors for Myocardial infarction and death in newly detected NIDDM: the Diabetes intervention study, 11 - year follow - up.Diabetologia 1996;39(12):15.
9Stock RP. Ningerling JR. de Jong PT. et al Retinopathy.glucose, and insulin in an elderly population. The Rotterdam study. Diabetes 1995;44(1):11.
